Rob Coppedge has managed Echo Health Ventures as chief executive since its creation in November 2016. Echo is a merger between health plans Cambia Health Solutions and Mosaic Health Solutions, a subsidiary of Blue Cross and Blue Shield of North Carolina (BCNC).
Cambia hired Coppedge in 2010 to conduct CVC deals. He co-founded Cambia Grove, an innovation hub focused on catalysing and supporting the Pacific Northwest’s emerging health care economic cluster. He now leads Echo to identify, invest in and grow innovative companies that enable and deliver a transformed experience to health care consumers nationwide.
In 2021, Echo launched its investment platform, Echo Innovation Alliance. The platform brings together Cambia Health Solutions, Mosaic Health Solutions, USAble Corporation – a wholly owned subsidiary of Arkansas Blue Cross Blue Shield – and BlueCross BlueShield of Tennessee to accelerate health care innovation on a national scale and drive meaningful health care impact. Echo enables health plans to collaborate on forward-looking health care innovation and deliver transformative products and services to over ten million members.
Among Echo’s most notable recent exits are the 2019 $167m IPO for health care software company Phreesia and the $355m IPO for digital health company Livongo. Echo recently invested in a $110m series D round for Scipher Medicine, a company building a precision medicine diagnostic platform. Echo also took the role as lead investor on the $20m series B round for Embold Health, a medical data analytics service.
Prior to joining Cambia, Coppedge was the founding partner of Faultline Ventures, where he worked with numerous early-stage companies and strategic investors. Previously, he was a partner at healthcare IT-focused VC firm Capitol Health Partners. Coppedge has a bachelor’s degree in history from Georgetown University in Washington DC.
